H.B. Matthews

Disposition and excretion of 2,3,7,8-tetrachlorodibenzofuran in the rat

The absorption, distribution, and excretion of the highly toxic halogenated aromatic hydrocarbon, 2,3,7,8-tetrachlorodibenzofuran (TCDF) was studied in the male Fischer rat. [14C]TCDF was completely absorbed after oral doses of 0.1 and 1.0 μmol/kg body wt. The distribution pattern was the same whether treatment was by oral or intravenous administration. The liver was the major depot of TCDF, with small amounts being redistributed to the skin and adipose tissue. TCDF was primarily excreted via the bile into the feces. Less than 6% was ever removed in the urine. More than half was excreted in the feces within 2 days. [14C]TCDF-derived radioactivity in the tissues cochromatographed with the parent compound, while in the excreta, only metabolites were detected. Thus, TCDF is readily absorbed, metabolized, and excreted in the feces. This rapid detoxification may account for the relative resistance of the rat to the acute toxicity of TCDF.

The effect of chlorine position on the distribution and excretion of four hexachlorobiphenyl isomers.

Abstract The distribution and excretion of four symmetrical polychlorinated biphenyl (PCB) isomers, 2,3,5,2′,3′,5′-hexa-; 2,3,6,2′,3′,6′-hexa-; 2,4,5,2′,4′,5′-hexa-; and 2,4,6,2′-4′,6′-hexachlorobiphenyl, were studied in the male rat. The study of three of these hexachlorobiphenyl isomers permitted an assessment of the importance of each unchlorinated position in the absence of adjacent unsubstituted carbon atoms on the biphenyl rings. The study of 2,3,6,2′,3′,6′-hexachlorobiphenyl allowed an assessment of the importance of adjacent unsubstituted carbon atoms in an otherwise highly chlorinated PCB. 2,3,6,2′,3′,6′-Hexachlorobiphenyl was rapidly metabolized and excreted relative to the hexachlorobiphenyls which did not have adjacent unsubstituted carbon atoms. The other hexachlorobiphenyls were very slowly metabolized by the male rat and have extremely long half-lives in this species. The results of these studies demonstrate the importance of adjacent unsubstituted carbon atoms to the metabolism of PCBs and imply that when the position of PCB chlorination is such as to inhibit the formation of an arene oxide intermediate then PCB metabolism proceeds very slowly. These studies allo indicate that in the absence of adjacent unsubstituted carbon atoms, the preferred mechanism of PCB metabolism may be by the insertion of a hydroxyl group at the meta position.

Metabolism of symmetrical hexachlorobiphenyl isomers in the rat

The excretion and metabolism of four symmetrical hexachlorobiphenyl [14C] isomers 2,3,5,2′,3′,5′-hexa-; 2,3,6,2′,3′,6′-hexa-; 2,4,5,2′,4′,5′-hexa-; and 2,4,6,2′,4′,6′-hexachlorobiphenyl, have been studied in the rat. Excretion of these hexachlorobiphenyl prior to metabolism to more polar compounds was negligible. Of the four isomers studied, the three which do not have vicinal unsubstituted carbon atoms were metabolized and excreted quite slowly. One isomer, 2,3,6,2′,3′,6′-hexachlorobiphenyl, which does have vicinal unsubstituted carbon atoms, was rapidly metabolized and excreted. The results indicate that the rate of metabolism and excretion of these hexachlorobiphenyl isomers depends on the position rather than the degree of chlorine substitution on the biphenyl ring. Metabolites of these hexachlorobiphenyl isomers were isolated from rat feces and identified by comparison of their mass and NMR spectral and chromatographic properties with synthetic metabolites. The hexachlorobiphenyl metabolites showed evidence of dechlorination, chlorine shifts, and possible metabolism via the direct insertion of a hydroxyl group. The nature of the metabolites of these hexachlorobiphenyl isomers strongly supports the intermediacy of an arene oxide as the predominant mechanism of PCB metabolism. Metabolism by direct insertion of a hydroxyl group is of importance only in the absence of vicinal unsubstituted carbon atoms and is facilitated by the presence of unchlorinated meta positions.

Allyl isothiocyanate: Comparative disposition in rats and mice

Allyl isothiocyanate (AITC), the major component of volatile oil of mustard, was recently reported to induce transitional-cell papillomas in the urinary bladder of male Fischer 344 rats, but not in the bladders of female rats or B6C3F1 mice. The present investigation of comparative disposition in both sexes of each species was designed to detect sex or species differences in disposition which might explain susceptibility to AITC toxicity. AITC was readily cleared from all rat and mouse tissues so that within 24 hr after administration less than 5% of the total dose was retained in tissues. The highest concentration of AITC-derived radioactivity was observed in male rat bladder. Clearance of AITC-derived radioactivity by each species was primarily in urine (70 to 80%) and in exhaled air (13 to 15%) with lesser amounts in feces (3 to 5%). Rats excreted one major and four minor metabolites in urine. The major metabolite from rat urine was identified by NMR spectroscopy to be the mercapturic acid N-acetyl-S-(N-allylthiocarbamoyl)-L-cysteine. Mice excreted in urine the same major metabolite identified in rat urine as well as three other major and two minor metabolites. Sex-related variations were observed in the relative amounts of these metabolites. Both species excreted a single metabolite in feces. Metabolism of AITC by male and female rats was similar, but female rats excreted over twice the urine volume of male rats. Results of the present study indicate that excretion of a more concentrated solution of AITC metabolite(s) in urine may account for the toxic effects of AITC on the bladder of male rats.

Comparison of lead bioavailability in F344 rats fed lead acetate, lead oxide, lead sulfide, or lead ore concentrate from Skagway, Alaska

An animal model using rats was developed to initiate investigations on the bioavailability of different sources of environmental lead. Lead must be absorbed and transported to target organs like brain, liver, kidney, and bone, before susceptible cells can be harmed. The bioavailability and therefore the toxicity of lead are dependent upon the route of exposure, dose, chemical structure, solubility, particle size, matrix incorporation, and other physiological and physicochemical factors. In the present study male F344 rats were fed < or = 38 microns size particles of lead sulfide, lead oxide, lead acetate, and a lead ore concentrate from Skagway, Alaska, mixed into the diet at doses of 0, 10, 30, and 100 ppm as lead for 30 d. No mortality or overt symptoms of lead toxicity were observed during the course of the study. Maximum blood lead concentrations attained in the 100 ppm groups were approximately 80 micrograms/dl in rats fed lead acetate and lead oxide, and were approximately 10 micrograms/dl in those fed lead sulfide and lead ore concentrate. Maximum bone lead levels in rats fed soluble lead oxide and lead acetate were much higher (approximately 200 micrograms/g) than those seen in rats fed the less soluble lead sulfide and lead ore (approximately 10 micrograms); kidney lead concentrations were also about 10-fold greater in rats fed the more soluble compared to the less soluble lead compounds. However, strong correlations between dose and tissue lead concentrations were observed in rats fed each of the four different lead compounds. Kidney lesions graded as minimal occurred in 7/10 rats fed 30 ppm and in 10/10 rats fed 100 ppm lead acetate, but not at lower doses or from other lead compounds. Similarly, urinary aminolevulinic acid excretion, a biomarker for lead toxicity, was increased in rats fed 100 ppm lead acetate or lead oxide, but was unaffected at lower doses or by the less soluble lead compounds. Although the histological and biochemical responses to lead toxicity were restricted to the more soluble lead compounds in this study, lead from Skagway lead ore concentrate and lead sulfide was also bioavailable, and accumulated in proportion to dose in vulnerable target organs such as bone and kidney. Longer-term studies with different mining materials are being conducted to determine if tissue lead continues to increase, and whether the levels attained are toxic. Data from such studies can be used to compare the toxicity and bioavailability of lead from different sources in the environment.

Physiological model for the pharmacokinetics of 2,3,7,8-tetrachlorodibenzofuran in several species

A flow-limited physiological model was developed to describe the time course of 2,3,7,8-tetrachlorodibenzofuran (TCDF) in the blood and tissues of rats, mice, and monkeys. The liver showed the greatest tendency to concentrate the material with tissue-to-blood distribution coefficients ranging from 30 in the monkey to 130 in the mouse. TCDF was also concentrated in the fat with tissue-to-blood distribution coefficients between 25 and 40 in all species. TCDF was eliminated by metabolism followed by excretion primarily to the feces. Urinary excretion was a minor route of elimination in all species. Metabolism was modeled as a linear process occurring in the liver. Intrinsic metabolic clearances ranged from 0.45 ml/min/kg in the monkey to 2.8 ml/min/kg in one species of mice. Fecal excretion of TCDF-derived radioactivity can be simulated with a series of well-mixed compartments which receive input of metabolites in the bile.

Correlation of hepatocellular proliferation with hepatocarcinogenicity induced by the mutagenic noncarcinogen : carcinogen pair : 2,6- and 2,4-diaminotoluene

2,4-Diaminotoluene (2,4-DAT) and 2,6-diaminotoluene (2,6-DAT) are equally genotoxic in the Ames/Salmonella assay and are both readily absorbed, metabolized, and excreted and metabolites of both compounds are mutagenic with metabolic activation. However, there are marked differences in the results of chronic rodent bioassays with these two compounds. 2,4-DAT is a potent hepatocarcinogen whereas 2,6-DAT failed to produce an increased incidence of tumors in any tissue even when administered at a dose higher than that of 2,4-DAT. In an effort to elucidate the source of these apparently discordant results, the present studies were designed to determine the effects of these two chemicals on cell proliferation in the liver when administered at the dose levels comparable to those used in the original bioassays. This study utilized repeated oral dosing, osmotic minipumps to deliver bromodeoxyuridine (BrDU) for 8 days, and immunohistochemistry to quantitate BrDU incorporation into hepatic DNA, CCl4 (0.4 ml/rat, single ip dose) or vehicle control groups were included as positive and negative controls, respectively. The degree of cell proliferation was quantified by the labeling index from at least 1000 hepatocytes. Results from the control studies indicate that approximately 1.1% of the hepatocytes from vehicle-treated animals replicated during the exposure period whereas approximately 50% replicated in the positive controls. The carcinogen 2,4-DAT produced a dose-dependent increase in cell proliferation of approximately 10% and 20% in livers of animals exposed to 12.5 and 25.0 mg/kg/day, respectively, whereas the noncarcinogen 2,6-DAT produced no increase in cell turnover compared to vehicle control following treatment with 25.0 or 50.0 mg/kg/day. These results indicate a positive correlation between increased cell proliferation and hepatocarcinogenesis induced by these two isomers of diaminetoluene.

Toxicity and Carcinogenicity of Chronic Exposure to Tris(2-chloroethyl)phosphate

Previous short-term studies of tris(2-chloroethyl)phosphate (TRCP), a flame retardant used in industrial and consumer products, demonstrated that repeated administration of 350 mg TRCP/kg body wt by oral gavage resulted in necrosis of pyramidal neurons in the CA1 region of the hippocampus of F344 rats, but not in B6C3F1 mice. The 2-year studies reported here were designed to characterize the chronic toxicity and potential carcinogenicity of TRCP in each sex of F344 rats and B6C3F1 mice. Groups of 60 rats per sex received 0, 44, or 88 mg/kg by oral gavage, once per day, 5 days per week, for up to 103 weeks. Groups of 60 mice per sex received 0, 175, or 350 mg/kg by oral gavage on the same dosing schedule. Each of these groups contained 10 animals which were euthanized at 66 weeks. The principal toxic effects of chronic exposure of rats to TRCP occurred in the brain and kidney. In contrast to the findings in the 16-week studies, a hippocampal lesion was not observed in the brain, although degenerative lesions were widely distributed in the gray and white matter of the brain stem and cerebral cortex of high-dose female and, to a lesser extent, male rats. These findings suggest that the hippocampal necrosis may be dependent upon the size of the individual doses or may have a pathogenesis different from that of the lesions in the brain stem and cerebral cortex. The other primary effect of chronic exposure was a dose-dependent increased incidence of renal tubule hyperplasia and adenoma.(ABSTRACT TRUNCATED AT 250 WORDS)

Distribution and excretion of 2,3,7,8-tetrachlorodibenzofuran in C57BL/6J and DBA/2J mice

Abstract The distribution and excretion of the toxic pollutant, 2,3,7,8-tetrachlorodibenzofuran (TCDF), was studied in male C57BL/6J and DBA/2J mice (22–29 g). [ 14 C]TCDF was administered iv at a dose of 0.1 μmmol/kg. The liver was the major site of TCDF accumulation, with more TCDF in the livers of C57BL/6J mice compared to DBA/2J mice. TCDF had a half-life of approximately 1.8 days in the livers of both strains. At 7 hr and 1 day, respectively, radioactivity was redistributed to adipose tissue of C57BL/6J mice and DBA/2J mice. The terminal T 1 2 of TCDF in adipose tissue of C57BL/6J mice was 1.1 days, whereas it was 6.8 days in DBA/2J mice; the sixfold longer half-life in DBA/2J mice may be related to the approximately 36% greater adipose tissue content of this strain which may sequester more TCDF. More than 80 and 55% of the dose was excreted in the feces of C57BL/6J and DBA/2J mice, respectively, within 10 days as polar metabolites. The whole body half-life of TCDF was 2 days in C57BL/6J and 4 days in DBA/2J mice. Thus, DBA/2J mice sequester more of the TCDF dose in adipose tissue, accounting for a relatively slower rate of clearance and lower concentrations of TCDF at the putative target site(s) for toxic action.

Acute exposure to tris(2-chloroethyl)phosphate produces hippocampal neuronal loss and impairs learning in rats☆

Adult female, Fischer-344 rats were exposed to 275 mg/kg of tris(2-chloroethyl)phosphate (TRCP) by gavage. TRCP produced consistent signs of convulsive activity within 60-90 min after dosing and extensive loss of CAT hippocampal pyramidal cells when examined 7 days after dosing. At the light microscopic level, toxic effects of TRCP on pyramidal cells in the CA3 and CA4 regions and on granule cells in the dentate gyrus were less severe than those on the CA1 cells. The seizure-related and neurohistological effects of TRCP were significantly attenuated by pretreatment with atropine or chlordizepoxide, suggesting that the hippocampal damage was related to the seizures produced by TRCP. In a second experiment designed to assess the potential health risk associated with TRCP, exposed rats were mildly impaired in the acquisition of a reference memory task in a water maze. However, TRCP-exposed rats were consistently impaired in performing a repeated acquisition task in the water maze. These data underscore the potential health risk associated with exposure to TRCP and support the conclusion that the hippocampus is intimately involved in spatial memory in rats.